 experi third-gener implant cardioverter-defibril medtron pacemak cardioverter-defibril patient mean age year sustain ventricular tachycardia VT ventricular fibril VF organ heart diseas mean ventricular eject fraction endocardi epicardi defibril shock efficaci implant shock pattern monophas singl sequenti simultan shock dual tripl electrod configur endocardi lead common right ventricular cathod dual anod epicardi lead helic coil patch VT termin pace shock therapi shock VF programm bradycardia pace individu zone VT VF detect individu pace shock therapi VT VF monophas shock epicardi defibril threshold compar sequenti simultan shock VT detect rate ms VF detect rate VT VF induct patient implant rapid patient low-energi shock patient high-energi shock patient therapi patient intermedi high-energi shock induc VF episod follow-up month noncardiac death electr therapi patient VT patient VT VF patient indetermin tachyarrhythmia patient vt/vf episod spontan VT episod follow-up reprogram patient success applic individu electr therapi prescript patient vt/vf feasibl therapi effect induc VT effect long-term spontan VT termin conjunct shock therapi patient exposur therapi programm hybrid pacemak cardioverter-defibril system nonthoracotomi implant effect vt/vf termin demand ventricular pace noninvas mode arrhythmia induct event monitor clinic trouble-shoot